Dr. Ruiz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-732-5500
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Dermatology, 2011 - 2014
NYU Grossman School of MedicineInternship, Internal Medicine, 2010 - 2011- New York University School of MedicineClass of 2010
Certifications & Licensure
MA State Medical License 2014 - 2025
NY State Medical License 2011 - 2015- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 87 citationsClinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes DataPritesh S. Karia, Frederick C. Morgan, Emily S. Ruiz, Chrysalyne D. Schmults
JAMA Dermatology. 2017-08-01 - 113 citationsPerformance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamou...Emily S. Ruiz, Pritesh S. Karia, Robert J. Besaw, Chrysalyne D. Schmults
JAMA Dermatology. 2019-07-01 - 20 citationsAdjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-cent...Emily S Ruiz, Kylee J B Kus, Timothy D Smile, Fadi Murad, Guohai Zhou
Journal of the American Academy of Dermatology. 2022-07-01
Press Mentions
Castle Biosciences Presents New Data at ASDS from Prospective, Multicenter CONNECTION Study Supporting Use of DecisionDx®-Melanoma to Guide SLNB Decisions in T1a Tumors with High-Risk Features and T1b TumorsOctober 20th, 2024- Study Confirms the Ability of Castle Biosciences’ DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell CarcinomaSeptember 5th, 2024
- Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck CancerMarch 18th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
